ROCKVILLE, Md. and HONG KONG /PRNewswire/ - Ascentage Pharma, a global clinical-stage biopharmaceutical company dedicated to developing apoptosis-targeted therapies for cancers and other diseases, today announced the formation of a Clinical Advisory Board (CAB) to provide strategic guidance to the Company as it advances its pipeline of novel, apoptosis-targeted therapies and next-generation tyrosine kinase inhibitors. The newly formed board
Read More ›